Dr Dinesh Mahendran, Consultant Endocrinologist at The Metabolic Clinic, was invited to share insights on CNA938 on the complex relationship between obesity, hormones, stress and mental health, and explains why weight gain is often driven by metabolic and hormonal factors rather than willpower alone
hypochondriacus ) and other carotenoids (Sarker and Oba, 2019b, 2020)
One of these applications describes pairing GLP-1 medications with another type of drug that blocks orexin receptors (orexin-1 or orexin-2) in the brain for treating opioid addiction
Werner T, Wagner SJ, Martnez I, Walter J, Chang J-S, Clavel T, et al
Starting with a known quantity and quality is the first step toward reliable research
However, concerns have been raised over whether GLP-1 receptor agonists reduce weight (often measured by body mass index, or BMI) mainly via muscle mass loss, which could lead to physical frailty or sarcopenia